163 related articles for article (PubMed ID: 36539667)
21. Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP).
Meyer zu Schwabedissen HE; Grube M; Dreisbach A; Jedlitschky G; Meissner K; Linnemann K; Fusch C; Ritter CA; Völker U; Kroemer HK
Drug Metab Dispos; 2006 Apr; 34(4):524-33. PubMed ID: 16415123
[TBL] [Abstract][Full Text] [Related]
22. Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells.
Kania KD; Wijesuriya HC; Hladky SB; Barrand MA
Brain Res; 2011 Oct; 1418():1-11. PubMed ID: 21920506
[TBL] [Abstract][Full Text] [Related]
23. Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2.
Bakhsheshian J; Wei BR; Chang KE; Shukla S; Ambudkar SV; Simpson RM; Gottesman MM; Hall MD
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20801-6. PubMed ID: 24297888
[TBL] [Abstract][Full Text] [Related]
24. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.
Cisternino S; Mercier C; Bourasset F; Roux F; Scherrmann JM
Cancer Res; 2004 May; 64(9):3296-301. PubMed ID: 15126373
[TBL] [Abstract][Full Text] [Related]
25. An electrically tight in vitro blood-brain barrier model displays net brain-to-blood efflux of substrates for the ABC transporters, P-gp, Bcrp and Mrp-1.
Helms HC; Hersom M; Kuhlmann LB; Badolo L; Nielsen CU; Brodin B
AAPS J; 2014 Sep; 16(5):1046-55. PubMed ID: 24934296
[TBL] [Abstract][Full Text] [Related]
26. Bisphenol A Inhibits the Transporter Function of the Blood-Brain Barrier by Directly Interacting with the ABC Transporter Breast Cancer Resistance Protein (BCRP).
Engdahl E; van Schijndel MDM; Voulgaris D; Di Criscio M; Ramsbottom KA; Rigden DJ; Herland A; Rüegg J
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073890
[TBL] [Abstract][Full Text] [Related]
27. Effects of bacterial and viral pathogen-associated molecular patterns (PAMPs) on multidrug resistance (MDR) transporters in brain endothelial cells of the developing human blood-brain barrier.
Lye P; Bloise E; Matthews SG
Fluids Barriers CNS; 2023 Jan; 20(1):8. PubMed ID: 36721242
[TBL] [Abstract][Full Text] [Related]
28. ATP-binding cassette transporters in primary central nervous system lymphoma: decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells.
Sakata S; Fujiwara M; Ohtsuka K; Kamma H; Nagane M; Sakamoto A; Fujioka Y
Oncol Rep; 2011 Feb; 25(2):333-9. PubMed ID: 21165575
[TBL] [Abstract][Full Text] [Related]
29. Expression of BCRP/ABCG2 Protein in Invasive Breast Cancer and Response to Neoadjuvant Chemotherapy.
Zhang YS; Yang C; Han L; Liu L; Liu YJ
Oncol Res Treat; 2022; 45(3):94-101. PubMed ID: 34775385
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer resistance protein/ABCG2 is differentially regulated downstream of extracellular signal-regulated kinase.
Imai Y; Ohmori K; Yasuda S; Wada M; Suzuki T; Fukuda K; Ueda Y
Cancer Sci; 2009 Jun; 100(6):1118-27. PubMed ID: 19514121
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer resistance protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1) restrict oral availability and brain accumulation of the PARP inhibitor rucaparib (AG-014699).
Durmus S; Sparidans RW; van Esch A; Wagenaar E; Beijnen JH; Schinkel AH
Pharm Res; 2015 Jan; 32(1):37-46. PubMed ID: 24962512
[TBL] [Abstract][Full Text] [Related]
32. Re-evaluation of the hCMEC/D3 based in vitro BBB model for ABC transporter studies.
Balzer V; Poc P; Puris E; Martin S; Aliasgari M; Auriola S; Fricker G
Eur J Pharm Biopharm; 2022 Apr; 173():12-21. PubMed ID: 35227855
[TBL] [Abstract][Full Text] [Related]
33. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
Dai CL; Liang YJ; Wang YS; Tiwari AK; Yan YY; Wang F; Chen ZS; Tong XZ; Fu LW
Cancer Lett; 2009 Jun; 279(1):74-83. PubMed ID: 19232821
[TBL] [Abstract][Full Text] [Related]
34. Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: A first step of a potential strategy for the treatment of Alzheimer's disease.
Arduino I; Iacobazzi RM; Riganti C; Lopedota AA; Perrone MG; Lopalco A; Cutrignelli A; Cantore M; Laquintana V; Franco M; Colabufo NA; Luurtsema G; Contino M; Denora N
Int J Pharm; 2020 Dec; 591():120011. PubMed ID: 33115695
[TBL] [Abstract][Full Text] [Related]
35. ATP-binding cassette transporter G2 mediates the efflux of phototoxins on the luminal membrane of retinal capillary endothelial cells.
Asashima T; Hori S; Ohtsuki S; Tachikawa M; Watanabe M; Mukai C; Kitagaki S; Miyakoshi N; Terasaki T
Pharm Res; 2006 Jun; 23(6):1235-42. PubMed ID: 16715370
[TBL] [Abstract][Full Text] [Related]
36. Effects of α-adrenoceptor antagonists on ABCG2/BCRP-mediated resistance and transport.
Takara K; Yamamoto K; Matsubara M; Minegaki T; Takahashi M; Yokoyama T; Okumura K
PLoS One; 2012; 7(2):e30697. PubMed ID: 22355323
[TBL] [Abstract][Full Text] [Related]
37. Glucocorticoids modulate multidrug resistance transporters in the first trimester human placenta.
Lye P; Bloise E; Nadeem L; Gibb W; Lye SJ; Matthews SG
J Cell Mol Med; 2018 Jul; 22(7):3652-3660. PubMed ID: 29691980
[TBL] [Abstract][Full Text] [Related]
38. A new intestinal cell culture model to discriminate the relative contribution of P-gp and BCRP on transport of substrates such as imatinib.
Graber-Maier A; Gutmann H; Drewe J
Mol Pharm; 2010 Oct; 7(5):1618-28. PubMed ID: 20701289
[TBL] [Abstract][Full Text] [Related]
39. Effect of Insulin Receptor-Knockdown on the Expression Levels of Blood-Brain Barrier Functional Proteins in Human Brain Microvascular Endothelial Cells.
Nagano H; Ito S; Masuda T; Ohtsuki S
Pharm Res; 2022 Jul; 39(7):1561-1574. PubMed ID: 34811625
[TBL] [Abstract][Full Text] [Related]
40. Function of Multidrug Resistance Transporters is Disrupted by Infection Mimics in Human Brain Endothelial Cells.
Eustaquio Do Imperio G; Lye P; Bloise E; Matthews SG
Tissue Barriers; 2021 Apr; 9(2):1860616. PubMed ID: 33427563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
